Orin Chisholm is the Program Authority and Senior Lecturer in Pharmaceutical Medicine in the School of Medical Sciences at UNSW. After undergraduate studies in biochemistry at The University of Sydney and doctoral studies in molecular biology and oncology at the Children’s Medical Research Foundation, Orin followed a research and academic pathway for several years. She undertook research appointments at leading medical research institutes in New York, Melbourne, Canberra and Sydney, where her research focussed on a molecular understanding of haemopoiesis. She also developed expertise in undergraduate teaching in the areas of biochemistry, molecular genetics, immunology and biotechnology.
Orin has worked in the pharmaceutical industry, predominantly in the area of Regulatory Affairs, where she has over 12 years experience. She has worked in both large pharmaceutical and smaller biotechnology companies in Australia and has expertise in the registration of small molecule and biotechnology products, particularly in the area of oncology. She also worked at Medicines Australia as their scientific manager during the initial consultation period for ANZTPA. She has lectured since 2005 at the University of Sydney in their Molecular Biotechnology program on the regulation of biotechnology products in Australia.
Orin is a member of ARCS, DIA and RAPS. Her current research interests lie in the area of regulatory science.